Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
nizofenone fumarate
- Development stage
- Unknown
- Lead developer
- Mitsubishi Tanabe Pharma
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Nizofenone fumarate is a neuroprotective small molecule originally developed by Yoshitomi Pharmaceutical (now Mitsubishi Tanabe Pharma) under the code Y-9194. It is primarily indicated for the improvement of neurological symptoms and the prevention of cerebral vasospasm following subarachnoid hemorrhage (SAH). The drug acts by inhibiting lipid peroxidation and protecting neuronal membranes from oxidative stress and ischemic injury. While it has been marketed in Japan under the brand name Midron, Chunfeng Pharmaceutical holds a Chinese patent (ZL201110375763.0) for a refining method of the compound, indicating its role in the manufacturing or development of the drug in the Chinese market.
- Brand names
- Midron
- Other names
- nizofenone2'-(2-aminoethyl)-5-chlorobenzophenone fumarate
02
Targets
TXA2 (Thromboxane A2)Reactive oxygen species and lipid peroxyl radicals
Beyond the preview
Go deeper on nizofenone fumarate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on nizofenone fumarate.